This inventor holds 1 USPTO granted patent. Top assignees: ETH Zurich, Universitât Bern. Active years: 2023.
Company Filing History:


Years Active: 2023
Title: Hirosaka Hayashi: Innovator in Inositol Derivatives
Introduction
Hirosaka Hayashi is a notable inventor based in Zürich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inositol derivatives.
Latest Patents
Hayashi holds a patent for "Inositol derivatives for use in pathological crystallization." This invention pertains to an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, aimed at treating or preventing diseases associated with the formation of calcium salt crystals. He has 1 patent to his name.
Career Highlights
Throughout his career, Hayashi has worked with prestigious institutions such as ETH Zurich and Universität Bern. His work has focused on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Hayashi has collaborated with notable colleagues, including Anna Kletzmayr and Makoto Kuro-o. These partnerships have further enriched his research and development efforts.
Conclusion
Hirosaka Hayashi's work in the field of inositol derivatives showcases his commitment to advancing medical science. His innovative patent reflects the potential for significant impact in treating diseases related to calcium salt crystallization.